Stem Cell Research

Little Hoover: Stem Cell Agency Board Should Shrink, Restructuring Needed

Joe Mathews — Fri, 26 Jun 2009 17:31:00 -0400

California's Little Hoover Commission, which investigates government agencies and focuses on efficiency, is out with a thoughtful new report on the state's stem cell agency and its governing board.

The report concludes that the board of the California Institute for Regenerative Medicine (CIRM) is too large and that the initiative that created the agency, Prop 71 in 2004, is "overly prescriptive" and locks in place too many inefficiencies. I reported as much last month in the Scientific American.

Among the major recommendations, from a summary released by Little Hoover:

"-Restructure the CIRM governing board around principles of efficiency and
transparency. The board size should be reduced to 15 from 29, maintaining the
diversity of membership but adding independent voices to the board. Board terms
should be shortened to four years for all members and the appointment process should
be streamlined. To eliminate overlapping authority and enhance accountability, the
roles of chair and president should be restructured and clarified. To minimize
disruption that can occur through turnover and changes in the governance structure,
new board members should be phased in as terms expire. The ICOC name also should
be changed to the Board of Directors to more accurately reflect its composition.
Improve the process for distributing grant and loan funds. To enhance
efficiency and transparency, the 50-employee cap on staffing should be removed, as
should the 15-person limit on peer reviewers. CIRM should modify its triage plan to
review grants internally. CIRM also should explore options for greater disclosure of the
peer review process and amend all meeting minutes to specify individual board
members' votes and recusals, and continue the practice moving forward.

"-Enhance oversight of CIRM. The Citizens Financial Accountability Oversight
Committee (CFAOC) and the CIRM governing board should use their authority to
enhance oversight. The CFAOC, chaired by the State Controller, should exercise its
existing authority, or be statutorily authorized if necessary, to conduct performance
audits and hold regular meetings to review CIRM's programmatic and strategic
performance, in addition to overseeing CIRM's annual financial audits. The CIRM
governing board should hold its members accountable by adopting removal provisions
in its bylaws.

"-Require the CIRM governing board to begin planning for CIRM's future. To
prepare for change in leadership, the CIRM governing board should create succession
plans for board leadership through an open process. The agency should include in its
strategic plan clear direction for spending funds, with measurable benchmarks and a
transition plan for when bond funding expires."

Prop 71 Author to Step Down as Chair of California Stem Cell Agency

Joe Mathews — Sat, 20 Jun 2009 04:49:00 -0400

Bob Klein, the Northern California developer who chaired the board of the state stem cell agency created by the 2004 ballot initiative he wrote, has announced he will step down at the end of 2010. That would mark the end of his six-year term.

Klein is a polarizing figure in California politics. And the stem cell initiative, Prop 71, remains controversial five years after it was passed. Supporters saw it as giving California a leadership role in an important area of research. Critics saw it as a financial boondoggle and an example of the ballot box budgeting that has helped put California in a fiscal hole.

John Simpson, who tracks the agency for Consumer Watchdog and broke the news of Klein's decision, has details here.

The Curious Case of California's Stem Cell Board

Joe Mathews — Wed, 20 May 2009 12:26:00 -0400

In this Scientific American piece, I explain how the creation of California's stem cell agency (and its governing board) by ballot initiative both protects and constrains the pursuit of stem cell research here.

Two Michigan Measures Reach The Ballot, But Not Democratic Initiative

Joe Mathews — Tue, 26 Aug 2008 13:23:00 -0400

Two Michigan measures -- one to lift restrictions on stem cell research, the other to permit use of marijuana for medical purposes -- have qualified for the ballot. But a third measure -- the Democratic-inspired initiative to cut legislators' pay, change the courts, and downsize the legislature -- was not placed on the ballot. (This is the measure, you'll recall, that was billed as a goo-goo reform effort before the discovery of a Power Point presentation that showed it to be part of a labor-Democrat effort to curb the mostly Republican courts). A court likely will decide whether that initiative makes the ballot. The AP sums it up.